It has been reported that EBNA1 impairs p53 activity through different mechanisms [206] and that the EBNA1-VAV1 interaction impairs BIM expression [207], altogether conferring resistance to apoptosis in BL. Here, BCL2L11 is linked to Burkitt lymphoma.